EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cell cycle machinery in oncology: A comprehensive review of therapeutic targets

Simona Cavalu iD, Amir Mohamed Abdelhamid iD, Sameh Saber iD, Elsayed A Elmorsy iD, Rabab S Hamad iD, Mustafa Ahmed Abdel-Reheim iD, Galal Yahya iD, Mohamed M Salama iD

The FASEB Journal · 15.06.2024 · 38 (11)

DOI: 10.1096/fj.202400769r ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 07.06.2024. Verfasst von Simona Cavalu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Pharmacy, University of Oradea, Oradea, Romania. Hauptthemen laut MEDLINE: Neoplasms, Cell Cycle. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Oradea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cell cycle is tightly regulated to ensure controlled cell proliferation. Dysregulation of the cell cycle machinery is a hallmark of cancer that leads to unchecked growth. This review comprehensively analyzes key molecular regulators of the cell cycle and how they contribute to carcinogenesis when mutated or overexpressed. It focuses on cyclins, cyclin‐dependent kinases (CDKs), CDK inhibitors, checkpoint kinases, and mitotic regulators as therapeutic targets. Promising strategies include CDK4/6 inhibitors like palbociclib, ribociclib, and abemaciclib for breast cancer treatment. Other possible targets include the anaphase‐promoting complex/cyclosome (APC/C), Skp2, p21, and aurora kinase inhibitors. However, challenges with resistance have limited clinical successes so far. Future efforts should focus on combinatorial therapies, next‐generation inhibitors, and biomarkers for patient selection. Targeting the cell cycle holds promise but further optimization is necessary to fully exploit it as an anti‐cancer strategy across diverse malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCell CycleHumansAntineoplastic AgentsProtein Kinase InhibitorsAnimalsMolecular Targeted Therapy

Stichwörter der Autor:innen

CDKcell cyclecyclinsmitosistherapeutic target

Substanzen

Antineoplastic AgentsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Faculty of Medicine and Pharmacy, University of Oradea, Oradea, Romania.
  • Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.
  • Department of Pharmacology and Therapeutics, College of Medicine, Qassim University, Buraidah, Saudi Arabia.
  • Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
  • Biological Sciences Department, College of Science, King Faisal University, Al Ahsa, Saudi Arabia.
  • Central Laboratory, Theodor Bilharz Research Institute, Giza, Egypt.

ORCID-Profile: Simona Cavalu, Amir Mohamed Abdelhamid, Sameh Saber, Elsayed A Elmorsy, Rabab S Hamad, Mustafa Ahmed Abdel-Reheim, Galal Yahya, Mohamed M Salama

Förderung

  • University of Oradea

Zitieren

APA

Cavalu, S., Abdelhamid, A. M., Saber, S., Elmorsy, E. A., Hamad, R. S., Abdel-Reheim, M. A., Yahya, G., & Salama, M. M. (2024). Cell cycle machinery in oncology: A comprehensive review of therapeutic targets. The FASEB Journal, 38(11). https://doi.org/10.1096/fj.202400769r

Vancouver

Cavalu S, Abdelhamid AM, Saber S, Elmorsy EA, Hamad RS, Abdel-Reheim MA, et al. Cell cycle machinery in oncology: A comprehensive review of therapeutic targets. The FASEB Journal. 2024;38(11). doi:10.1096/fj.202400769r

BibTeX
@article{Cavalu2024,
  author = {Cavalu, Simona and Abdelhamid, Amir Mohamed and Saber, Sameh and Elmorsy, Elsayed A and Hamad, Rabab S and Abdel-Reheim, Mustafa Ahmed and Yahya, Galal and Salama, Mohamed M},
  title = {Cell cycle machinery in oncology: A comprehensive review of therapeutic targets},
  journal = {The FASEB Journal},
  year = {2024},
  volume = {38},
  number = {11},
  doi = {10.1096/fj.202400769r}
}
Kostenlos starten →